Nasofan Allergy (Fluticasone Propionate)

Fluticasone propionate is a synthetic corticosteroid that binds to glucocorticoid receptors in the cells lining the nasal passages. This binding alters gene transcription, decreasing the production of inflammatory cytokines and limiting the migration of immune cells into the nasal mucosa, which in turn reduces swelling and mucus formation.

The appropriate dose of Nasofan Allergy is determined by a qualified prescriber based on the patient’s age, severity of symptoms and clinical response. Typical regimens involve one or two sprays per nostril once daily, but exact instructions should always follow the healthcare professional’s prescription.

Safety data for fluticasone propionate nasal spray in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before starting treatment.

To place an order, visit the product page on gnhindia.com, enter the required quantity and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nasofan Allergy (fluticasone propionate) and other intranasal corticosteroids such as mometasone furoate have similar efficacy in controlling allergic rhinitis. Fluticasone has a well‑established safety profile and once‑daily dosing, while some alternatives may offer different dosing frequencies or device designs. Choice often depends on patient preference, tolerability and prescriber experience.

Store Nasofan Allergy at room temperature, ideally below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture, excessive heat and direct sunlight. Do not freeze the product, and discard any spray that appears discolored or has an abnormal odor.

Nasofan Allergy is administered as a nasal spray. The user should gently blow the nose, tilt the head slightly forward, insert the nozzle into one nostril, and press the actuator while breathing in gently through the nose. The same procedure is repeated for the other nostril if prescribed.

Serious risks, although rare, include adrenal suppression, severe nosebleeds, fungal infection of the nasal passages, allergic reactions that can progress to anaphylaxis, and perforation of the nasal septum. Patients should seek immediate medical attention if they experience unusual bleeding, persistent infections, vision changes or signs of an allergic reaction.

Nasofan Allergy should be avoided in individuals with known hypersensitivity to fluticasone propionate or any component of the formulation. It is also contraindicated in patients with active untreated fungal, viral or bacterial infections of the nasal mucosa, and in those who have had recent nasal surgery unless directed by a surgeon.